Slide 1 Dr. X. Baraliakos Rheumazentrum Ruhrgebiet, Herne Ruhr-University Bochum Germany Anti-TNF therapy in ankylosing spondylitis - Clinical and structural outcomes - Slide…

Slide 1 ASAS Berlin Meeting - Questionnaire Results ASAS – recent achievements 1.General remarks 2.Improvement Criteria 3.Anti-TNF Treatment recommendations Prof.J.Braun…

Microsoft Word - Guideline on Ankylosing Spondylitis- adoptedEuropean Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use 7 Westferry Circus, Canary

Guideline: On Clinical Investigation of Medicinal Products for the Treatment of Ankylosing SpondylitisEuropean Medicines Agency Evaluation of Medicines for Human Use 7 Westferry

ISBN: 978-94-6259-628-3 Copyright © 2015 JC van Denderen Cover: Ellen van Diek Layout: Persoonlijkproefschrift.nl, Matthijs Ariëns Printing: Ispkamp Drukkers, Enschede

SpondyloarthritidesKEYWORDS KEY POINTS Evaluation of a patient with a spondyloarthropathy should include consideration of possible complications of the disease as well as